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Background: High titers of lentiviral vectors are required for the efficient transduction of a gene of interest. During
preparation of lentiviral the vectors, the protein of interest is inevitably expressed in the viral vector-producing cells.
This expression may affect the production of the lentiviral vector.
Methods: We prepared lentiviral vectors expressing inwardly rectifying potassium channel (Lv-Kir2.1), its
dominant-negative form (Lv-Kir-DN), and other K+ channels, using the ubiquitously active β-actin and neuron-specific
synapsin I promoters.
Results: The titer of Lv-Kir-DN was higher than that of Lv-Kir2.1, suggesting a negative effect of induced K+ currents on
viral titer. We then blocked Kir2.1 currents with the selective blocker Ba2+ during Lv-Kir2.1 production, and obtained
about a 5-fold increase in the titer. Higher extracellular K+ concentrations increased the titer of Lv-Kir2.1 about 9-fold.
With a synapsin I promoter Ba2+ increased the titer because of the moderate expression of Kir2.1 channel. Channel
blockade also increased the titers of the lentivirus expressing Kv1.4 and TREK channels, but not HERG. The increase in
titer correlated with the K+ currents generated by the channels expressed.
Conclusion: In the production of lentivirus expressing K+ channels, titers are increased by blocking K+ currents in the
virus-producing cells. This identifies a crucial issue in the production of viruses expressing membrane channels, and
should facilitate basic and gene therapeutic research on channelopathies.
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Viral vectors, especially lentiviral vectors, are useful in
transducing genes of interest in vitro, in situ, and
in vivo. Lentiviral vectors are promising tools for gene
therapy because they can transduce postmitotic cells,
allow long-lasting expression, and exhibit low toxicity
and low oncogenic activity [1]. High-titer lentiviral vec-
tors are required for efficient transduction and time-
and cost-savings. Lentiviral vectors are usually produced
in 293T cells with the transfection of self-inactivating ex-
pression and helper plasmids [2]. Because most lentiviral
vectors contain ubiquitously active promoters, the pro-
teins of interest are inevitably expressed in the viral-* Correspondence: mokada-tky@umin.ac.jp
Department of Physiology, Kansai Medical University, 2-5-1 Shin-machi, Hirakata,
Osaka 573-1010, Japan
© 2015 Okada et al.; licensee BioMed Central.
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.vector-producing cells, possibly affecting their vector-
producing ability.
Potassium (K+) channels play pivotal roles in the regu-
lation of cellular excitability and in ion transport in ex-
citable and nonexcitable cells. Abnormalities of the K+
channels result in epilepsy, arrhythmia, and disturbances
of the immune system [3,4]. For instance, the loss-of-
function mutation of strongly inwardly rectifying K+
channel 2.1 (Kir2.1), which is expressed in the heart,
blood vessels, kidney, and brain, results in type I Ander-
sen–Tawil syndrome [5], and the Kir2.1 knockout
phenotype is lethal in mice, indicating the physiological
importance of the channel [6-8]. Therefore, lentiviral
vectors expressing K+ channels, including Kir2.1, may
offer possible treatments for some diseases. Studies have
shown that the adenoviral expression of Kir2.1 effect-
ively prevents hyperalgesia by suppressing the neuronalThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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been used to modulate the excitability of neural and car-
diac cells in experimental animals [10-12].
However, the overexpression of the renal outer medul-
lary K+ (ROMK; Kir1.1) channel resulted in neuronal de-
generation [13]. In viral-vector-producing cells, their
vector-producing capacity might be reduced by the ex-
pression of K+ channels. In this study, we report that the
production of a lentiviral vector expressing Kir2.1 was
increased by blocking the cellular Kir2.1 current during
its production. Blocking the channel also increased the
viral titer when the neuron-specific synapsin I promoter
was used. This method was partly applicable to lentiviral
vectors expressing other K+ channels, depending on the
currents in the resting state. This increase in viral titer
correlated with the cellular membrane potential, whose
major determinant is the K+ current, suggesting that the
effectiveness of the blockade can be predicted from the
membrane potential of K+-channel-expressing cells.
Results
Blocking the Kir2.1 current increases virus production
In our previous study, we prepared lentiviral vectors
that bicistronically coexpress Kir2.1 (Lv-Kir2.1) or the
dominant-negative form of Kir2.1 (Lv-Kir-DN) and
green fluorescent protein (GFP) [14] (Figure 1). In
these vectors, we used the chicken β-actin promoter
because among all the promoters tested by Okabe et al.
[15], it showed the most persistent and highest expres-
sion in hippocampal neurons. Because the β-actin pro-
moter is ubiquitously active, the Kir2.1 channels were
inevitably expressed in 293T cells during viral produc-
tion. To test whether their expression affects the viral-
vector-producing capacity of the cells, we prepared
these two viral vectors and compared their titers before
(unconcentrated) and after (concentrated) centrifugal
concentration. The titers of Lv-Kir2.1 were significantly
lower than those of Lv-Kir-DN in both the unconcentrated
(Figure 2A) and concentrated samples (Figure 2B), sug-
gesting that the Kir2.1 current had a negative effect on
viral vector production.
To confirm this negative effect, we added a selective
Kir2.1 channel blocker, Ba2+ (0.3 mM), to the culture
medium of the Lv-Kir2.1-producing cells immediately
after transfection. We then determined the titers of Lv-
Kir2.1 prepared in the presence or absence of Ba2+ with
the transduction to 293T cells. As expected, the addition
of Ba2+ significantly increased the lentiviral titers in both
the unconcentrated (Figure 2C) and concentrated sam-
ples (Figure 2D). Because we prepared the control and
Ba2+-treated samples concurrently using the same batches
of 293T cells and plasmids, the efficacy of plasmid trans-
fection should have been identical in both. To confirm
that Ba2+ increased the lentiviral titer by blocking theKir2.1 channels, we prepared a lentiviral vector that only
expressed GFP (Lv-GFP; Figure 1) in the presence or ab-
sence of 0.3 mM Ba2+. The addition of Ba2+ had no effect
on the titer of the unconcentrated sample (Figure 3A, n =
5), suggesting that Ba2+ acts on the Kir2.1 channel. Inter-
estingly, the titers of Lv-GFP were higher than those of
Lv-Kir2.1 (p < 0.05, n = 5, Student’s t test; see below).
To exclude the possibility that Ba2+ affects the infec-
tious ability of the Lv-Kir2.1 particle, we prepared Lv-
Kir2.1 without the addition of Ba2+ and concentrated it.
The infectious ability of the vector was then determined
with transduction to 293T cells in the presence or ab-
sence of 0.3 mM BaCl2. The addition of BaCl2 had no ef-
fect (Control 12.0 ± 1.7 × 104 iu/μl; BaCl2, 10.3 ± 1.8 ×
104 iu/μl; n = 8, p = 0.5, Student’s t test). Next, to exclude
the possibility that Ba2+ affects the stability of the lenti-
viral particle, Lv-Kir2.1 was incubated in medium with
or without 0.3 mM BaCl2 for 0, 4, 9, or 24 h at 37°C in a
96-well plate. We then measured the infectious ability of
the particle by adding 293T cells to each well and count-
ing the numbers of GFP-positive cell clusters after 48 h.
The half-life of the transduction ability of the particles
was estimated as the decline in the infectious units. The
addition of Ba2+ had no effect on the half-lives (control,
9.9 ± 2.5 h; BaCl2, 10.2 ± 1.4 h, n = 5).
Correlation between Lv-Kir2.1 titer and Kir2.1 current
To confirm the negative correlation between the K+
current and lentiviral production, we examined the Ba2+
concentration–response relationship for the Lv-Kir2.1
titer and for Kir2.1 conductance, and compared them.
To estimate the Ba2+ concentration dependence on the
titer, we prepared Lv-Kir2.1 in medium containing vary-
ing concentrations of Ba2+ (Figure 4A) and estimated
the half-maximal effective concentration (EC50). We also
measured the Kir2.1 conductance with varying concen-
trations of Ba2+ with the whole-cell voltage-clamp con-
figuration (Figure 4B) and estimated the half-maximal
inhibitory concentration (IC50) of Ba
2+. The EC50 of the
titer (14 μM) was similar to the IC50 of the conductance
(16 μM). We then analyzed the correlation between the
Lv-Kir2.1 titer and Kir2.1 conductance at various con-
centrations of Ba2+ (Figure 4C) and found a negative
correlation (R2 = 0.74).
To further verify that the K+ current decreased the
lentiviral titer, we tested the effect of higher extracellular
K+ concentrations, which reduced the K+ gradient. First,
we examined the effect of the higher K+ concentrations
on the whole-cell membrane potential of a Kir2.1-ex-
pressing cell with the whole-cell current-clamp method.
The resting membrane potential was depolarized accord-
ing to the extracellular K+ concentration (Figure 4D).
Lv-Kir2.1 was then prepared in medium containing









Figure 1 Schematic illustration of lentiviral vectors. Structures of the lentiviral self-inactivating expression plasmids Lv-Kir2.1, Lv-Kir-DN, Lv-GFP,
Lv-synapsinP-Kir2.1, Lv-ΔCMV-synapsinP-Kir2.1, Lv-ΔCMV-LTR-RRE-cPPT-synapsinP-Kir2.1, Lv-Kv1.4, Lv-TREK, and Lv-HERG. The upstream CMV
promoter was used to transcribe the viral genomic RNA. CMV, cytomegalovirus promoter; LTR, long terminal repeat; ψ, RNA packaging signal;
RRE, Rev-responsive element; cPPT, central polypurine tract; β-actin, promoter of chick β-actin gene; synapsin, human synapsin I promoter; GFP,
green fluorescent protein gene; NLS, nuclear localization signal; WPRE, posttranscriptional regulatory element of woodchuck hepatitis virus; ∇,
deletion in the U3 region of the 3′-LTR.
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increased (8.9-fold at 29 mM KCl; Figure 4E). The
changes in the lentiviral titer correlated well with the
membrane potential (R2 = 0.93; Figure 4F), supporting
the negative effect on the production of Lv-Kir2.1.
Higher transduction to neurons in hippocampal slices
To test whether target neurons were more effectively
transfected with Ba2+-treated higher-titer Lv-Kir2.1 thanby the control vector, we examined the transduction
ability to the hippocampal neurons. We injected con-
centrated Lv-Kir2.1 vector, prepared in the presence
or absence of Ba2+, into the CA1 pyramidal layer of a
hippocampal organotypic culture. The hippocampal
slices were incubated for 7 days, and then fixed and
counterstained with an antibody directed against
NeuN, a marker protein of neurons (Figure 5A). The
number of GFP-positive cells was significantly higher
- - - -. .
Figure 2 Current-blockade-dependent increase in the titer of Lv-Kir2.1. (A and B) The Lv-KirDN titer was higher than the Lv-Kir2.1 titer. The titers
were determined with aliquots prepared before (unconcentrated) and after (concentrated) centrifugal concentration. The titers of unconcentrated
and concentrated Lv-Kir-DN were both significantly higher than those of unconcentrated and concentrated Lv-Kir2.1 (n = 5; *p < 0.05, **p < 0.01,
Student’s t test). (C and D) Blocking the Kir2.1 current increased the titer of Lv-Kir2.1. After plasmid transfection, the 293T cells were incubated in
the presence or absence of 0.3 mM BaCl2 for 48 h. The addition of BaCl2 significantly increased the titers of both the unconcentrated and concentrated
Lv-Kir2.1 (n = 5; p < 0.05, Student’s t test).
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(Figure 5B).
Applicability to the vector of neuron-specific synapsin I
promoter
We then tested whether this method is applicable to a
vector that expresses Kir2.1 under the control of the
synapsin I promoter, which is considered to act select-
ively in neuronal cells [16]. We constructed the plasmid
Lv-synapsinP-Kir2.1, in which the β-actin promoter was
replaced with the human synapsin I promoter (Figure 1).
We prepared the lentiviral vector in the presence or ab-
sence of 0.3 mM BaCl2. The titer of the synapsin-
promoter-containing vector was determined with the
transduction to PC12 cells because the synapsin I pro-
moter activity is higher in PC12 cells than in 293T cells.
Interestingly, the addition of BaCl2 increased the titer
of Lv-synapsinP-Kir2.1 in both the unconcentrated
(Figure 6A) and concentrated samples (Figure 6B).
However, the degree of increase (1.8-fold) was smaller
than that observed for Lv-Kir2.1 (p < 0.05, Student’s ttest; n = 4 for Lv-synapsinP-Kir2.1 and n = 5 for
Lv-Kir2.1). The titers of Lv-synapsinP-Kir2.1 were
lower than those of Lv-Kir2.1, whose titers were deter-
mined in 293T cells, because titration using PC12 cells
underestimated the titers. For instance, titration with
PC12 cells underestimated the titers up to 7.0-fold,
even for Lv-Kir2.1 (data not shown).
The increase in the titer of Lv-synapsinP-Kir2.1 caused
by Ba2+ suggests that the Kir2.1 channels were moder-
ately expressed in 293T cells. If this is the case, GFP
should have also been expressed in the 293T cells be-
cause the Lv-synapsinP-Kir2.1 plasmid has a bicistronic
expression element, the internal ribosomal entry site
(IRES). We examined the GFP expression in 293T cells
transfected with plasmid Lv-Kir2.1 or Lv-synapsinP-
Kir2.1. As expected, the Lv-synapsinP-Kir2.1-transfected
cells expressed GFP 24 h after transfection (Figure 7C),
although the expression of GFP was lower than that in
the Lv-Kir2.1-transfected cells (Figure 7B).
This finding raises the question: which promoter medi-
ated the expression? There are two possibilities: synapsin
Figure 3 Channel blockers increase titers of Lv-Kv1.4 and Lv-TREK, but not those of Lv-GFP and Lv-HERG. (A) Ba2+ had no effect on the titer of
Lv-GFP. After 293T cells were transfected with Lv-GFP and helper plasmids, they were incubated in the presence or absence of 0.3 mM BaCl2 for
48 h. The titers in the unconcentrated aliquots were determined by measuring the number of GFP-positive cell clusters after the transduction to
293T cells (n= 5). (B) Increase in Lv-Kv1.4 titer. The addition of 4-AP (0.5 mM) significantly increased the titer of Lv-Kv1.4. Because the lentiviral vectors
prepared in the presence or absence of blocker were prepared concurrently, the data were analyzed with a paired t test (n = 5, p < 0.05). (C) Increase in
Lv-TREK titer. Similarly, the transfected 293T cells were incubated in the presence or absence of 1 mM BaCl2, and the titers were measured (p < 0.05,
n = 5). (D) No increase in Lv-HERG titer. In contrast, the addition of E-4031 did not increase the titer of Lv-HERG (n = 8).
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from the upstream CMV promoter might be translated
into Kir2.1 and GFP. To test these two possibilities, we
constructed the plasmid Lv-ΔCMV-synapsinP-Kir2.1, in
which the upstream CMV promoter was deleted from
Lv-synapsinP-Kir2.1, and used it to transfect 293T cells.
We observed slight expression of GFP in the cells 24 h
after the transfection of the plasmid (Figure 7D), which
was clearly higher than that in the mock-transfected
cells (compare with Figure 7A). This result suggests
that the synapsin promoter was moderately activated in
the 293T cells. Furthermore, the expression of GFP
from Lv-ΔCMV-synapsinP-Kir2.1 was lower than that
from Lv-synapsinP-Kir2.1 (compare Figure 7C and D),
suggesting that the transcript from the CMV promoter
was also translated to some extent.
To eliminate the possibility of a promoter activity in
the fragment containing the long terminal repeat (LTR),
central polypurine tract (cPPT), and between them, we
deleted that fragment (forming Lv-ΔCMV-LTR-RRE-cPPT-synapsinP-Kir2.1). The GFP expression from Lv-
ΔCMV-LTR-RRE-cPPT-synapsinP-Kir2.1 was similar
to that from Lv-ΔCMV-synapsinP-Kir2.1 (Figure 7E),
indicating the lack of promoter activity in the LTR-
RRE-cPPT fragment. The results are summarized in
Figure 7F.
Partial applicability to other K+ channels
The K+ channel family consists of more than 100 sub-
types and is the largest family of ion channels. We tested
whether the blockade method evaluated here increased
the titers of lentiviral vectors expressing other K+ chan-
nels. We constructed lentiviral vector plasmids that
expressed the shaker-type K+ channel (Kv1.4), TWIK-
related K+ channel (TREK-1c), and human ether-a-go-go
related gene (HERG) channel (Figure 1). We prepared
these lentiviral vectors in the presence or absence of a
blocker of each channel and measured the lentiviral ti-
ters in unconcentrated aliquots. These viral titers, in
samples prepared without a blocker, varied as follows:
-Figure 4 Correlation between Lv-Kir2.1 titer and Kir2.1 current. (A) Ba2+ concentration–Lv-Kir2.1 titer relationship (n= 4). (B) Ba2+ concentration–Kir2.1
conductance relationship (n = 4). These relationships were fitted to the Hill equation (four parameters). (C) Correlation between Kir2.1 conductance and
lentiviral titers at various concentrations of BaCl2. Values were normalized to that of 0.003 mM BaCl2 and were fitted by linear regression (R
2 = 0.74).
(D) Changes in the membrane potential at higher extracellular K+ concentrations. Tyrode’s solution, in which the K+ concentration was varied, was
perfused sequentially. (E) Extracellular-K+-concentration-dependent increase in the titer of Lv-Kir2.1. Lentiviral vectors were prepared with medium
containing 5, 13, 21, or 29 mM KCl. We determined the lentiviral titers and found significant differences at different extracellular K+-concentrations
(p < 0.0000000001, analysis of variance [ANOVA], n = 4). (F) Correlation between membrane potential and the Lv-Kir2.1 titer at various extracellular K+
concentrations. Values are the means of four experiments and were fitted with linear regression (R2 = 0.93).
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(Figures 3 and 8B). Interestingly, the channel blockade
increased the titers of Lv-TREK and Lv-Kv1.4, but not
that of Lv-HERG (Figure 3B, C and D). The degree of in-
crease caused by the addition of the blockers also varied
among the channels (Figures 3 and 8C, see below), in
the order: Lv-Kir2.1 > > Lv-TREK ≥ LvKv1.4 > Lv-GFP ≥
Lv-HERG, which was almost opposite the order de-
scribed above.
The lentiviral vector expressing Kv1.4, through which
a transient outward K+ current (IA) flows, was prepared
in the absence or presence of a low concentration
(0.5 mM) of the IA channel blocker, 4-aminoprydine (4-
AP), because higher concentrations of 4-AP affected cell
growth (not shown). As shown in Figure 3B, the addition
of 4-AP significantly increased the titer of the lentiviral
vector to 158.3 ± 12.6% of the control value.
Because the TREK-1c channel is partially blocked by
Ba2+ [17,18], we added 1 mM BaCl2 to the medium of
Lv-TREK-producing cells. This addition increased the
titer of Lv-TREK to 162 ± 15.8% of the control value
(Figure 3C). We also used bupivacaine, which is a more
potent blocker of TREK-1 [19], but unexpectedly, it de-
creased the lentiviral titer. This decrease was attributed
to the toxicity of bupivacaine [20] and confirmed by themorphological changes in the cells (not shown). We
measured the extent of the blockade with whole-cell
patch-clamp recordings and found that 1 mM BaCl2
blocked 34.0 ± 7.4% of the bupivacaine (1 mM)-sensitive
current expressed in 293T cells (n = 3). We also tested
the effect of a HERG-specific blocker, E-4031 (0.3 μM),
on the Lv-HERG titer, but its addition decreased the
titer insignificantly (89.6 ± 11.3%; Figure 3D).
Correlation between lentiviral titer and membrane
potential of cells expressing other K+ channels
To understand the variations in the lentiviral titers and
their increase by channel blockers, we measured the
membrane potentials of 293T cells expressing Kir2.1,
GFP, Kv1.4, TREK-1, or HERG. The voltage dependen-
cies of these K+ channels differ. For instance, the Kir2.1
channel conducts current at resting and hyperpolarized
potentials and is blocked during stronger depolarization.
In contrast, the HERG channel only opens during
depolarization. Therefore, the amplitude of the K+
current in the resting state should differ among these
viral-vector-producing cells, and might cause variations
in the lentiviral vectors’ titers and the degree of their in-
crease by channel blockers. We measured the membrane
potentials, which are largely determined by the K+
Figure 5 Higher transduction to the hippocampal neurons.
(A) Concentrated Lv-Kir2.1 vector, prepared in the absence or presence
of Ba2+, was injected under the same conditions (≈0.05 nl/site) into the
extracellular space of the CA1 pyramidal layer in organotypic cultures
of rat hippocampus. Seven days after injection, the cultured slices were
fixed with 4% paraformaldehyde and immunostained with anti-NeuN
antibody and a secondary antibody conjugated with Alexa Fluor 568.
The single-plane images were taken with a confocal microscope
(218 × 288 μm; FV300, Olympus). Bar, 50 μm. (B) Differences in the
numbers of GFP-positive cells. Numbers of GFP-positive cells seen
within the visual field described above were counted (n = 18 and
41, from three independent experiments; p < 0.00001, Student’s t test).
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mids 24 h after transfection. The membrane potentials
were significantly hyperpolarized in the Kv1.4-, TREK-1-,
and Kir2.1-expressing cells, in that order (Figure 8A).
However, the membrane potential of the HERG-
expressing cells was similar to that of the GFP-expressing
control cells.
We then assessed the correlation between the mem-
brane potentials of the expressing cells and the viral vec-
tor titers. The resting membrane potential tended to
correlate with the titers of the lentiviral vectors preparedwithout blockers (Figure 8B). We next assessed the rela-
tionship between these membrane potentials and the de-
gree of increase in the lentiviral titer induced by the
channel blockers (Figure 8C). The degree of increase
correlated negatively with the membrane potential, i.e.,
the more hyperpolarized the membrane, the larger the
increase in the lentiviral titer, except that the rank order
of Kv1.4 and TREK-1 was reversed. Therefore, the differ-
ence in the amplitude of the K+ current seemed to affect
the viral titers and the effectiveness of the blockade.
Reduced ATP in Lv-Kir2.1-producing cells
The cellular adenosine triphosphate (ATP) level is re-
portedly critical for virus production [21,22]. The over-
expression of the Kir2.1 channel might accelerate ATP
consumption by Na+/K+-ATPase during the intake of
K+, which is effluxed through the K+ channel, reducing
the cellular ATP. To clarify the mechanism underlying
the changes in the production of Lv-Kir2.1, we measured
the cellular ATP levels 48 h after the cells were trans-
fected with the plasmids. The ATP level in the Lv-
Kir2.1-producing cells was significantly lower (48.9%)
than that in the mock (no plasmid)-transfected cells
(Figure 8D). The addition of 0.3 mM Ba2+ restored the
ATP concentration to 75.5% of that in the mock-
transfected cells. Ba2+ did not affect the total cell num-
ber, which was estimated with microscopic counting and
the measurement of lactate dehydrogenase (LDH) activ-
ity in living cells lysed with detergent (data not shown).
Discussion
In this study, several lines of evidence showed that the ti-
ters of lentiviruses expressing K+ channels were increased
when the K+ current was blocked during preparation. This
evidence is as follows. (1) The titer of Lv-Kir-DN was
higher than the titer of Lv-Kir2.1. (2) The addition of Ba2+
increased the titer of Lv-Kir2.1. (3) A higher extracellular
K+ concentration increased the titer of Lv-Kir2.1, which
correlated with the membrane potential of the Kir2.1-
expressing cells. (4) Channel blockers increased the titers
of Lv-Kv1.4 and Lv-TREK, but not that of Lv-HERG. The
degree of the lentiviral increase caused by the channel
blockers correlated well with the cellular membrane po-
tential. (5) The titers of the lentiviral vectors expressing
these K+ channels, prepared without blockers, tended to
correlate with the membrane potential of the cells ex-
pressing each channel. Because the K+ current is the major
determinant of membrane potential, these results consist-
ently suggest that the viral-vector-producing ability is re-
duced by an excessive K+ current. Therefore, it seems that
larger K+ currents in the resting state caused lower lenti-
viral titers without blockers. In addition, the larger cur-
rents also resulted in higher degree of the increase in titers
with blockers. Membrane potential may be useful in
Figure 6 Blocking Kir2.1 current increased the titer of Lv-synapsinP-Kir2.1. (A and B) The titer of Lv-synapsinP-Kir2.1 was increased by blocking
the Kir2.1 current. The viral vector was prepared in the presence or absence of 0.3 mM BaCl2. The titers of unconcentrated (A) and concentrated








Figure 7 GFP expression from plasmids containing synapsin promoter. (A, B, C, D, and E) Expression of GFP with synapsin promoter plasmids.
293T cells were transfected with no plasmid (A), Lv-Kir2.1 (B), Lv-synapsinP-Kir2.1 (C), Lv-ΔCMV-synapsinP-Kir2.1 (D), or Lv-ΔCMV-LTR-RRE-cPPT-
synapsinP-Kir2.1 (E). Images were taken after 24 h under a microscope (IX70 Olympus). Bar, 50 μm. (F) Summary of GFP expression analyzed with
the ImageJ software. The whole-cell area of each cell was manually selected, and the average gray value (n = 50, from three independent
experiments) is presented as the fluorescence in arbitrary units (au) of the software (p < 0.000000001, ANOVA). Note the moderate GFP
expression in the Lv-synapsinP-Kir2.1-transfected cells (p < 0.005 vs mock transfection; post hoc Student’s t test) and its slight expression in
the Lv-ΔCMV-synapsinP-Kir2.1- (p < 0.01) and Lv-ΔCMV-LTR-RRE-cPPT-synapsinP-Kir2.1-transfected cells (p < 0.05). The GFP expression
in the two ΔCMV-plasmids-transfected cells was lower than that in the Lv-synapsinP-Kir2.1-transfected cells (p< 0.005). Schematic illustrations show
the difference in plasmid construction.
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Figure 8 Correlation between the resting membrane potential and lentiviral titer. (A) Resting membrane potentials of K+-channel-expressing
cells. 293T cells were transfected with plasmid Lv-GFP, Lv-HERG, Lv-Kv1.4, Lv-TREK, or Lv-Kir2.1. The membrane potentials of these K+-channel-expressing
cells were measured in the whole-cell current-clamp mode 24 h after transfection (*p < 0.05, **p < 0.000001 vs Lv-GFP; ANOVA followed by Student’s t
test, n = 5). (B) Correlations between membrane potential and the titers of the lentiviral vectors. The titers of the unconcentrated lentiviral vectors
encoding GFP, HERG, Kv1.4, TREK, and Kir2.1, prepared without blockers, tended to correlate with the membrane potentials of the 293T cells expressing
these channels. Linear regression was used to correlate the data (R2 = 0.59). (C) Correlation between membrane potential and the increase in
the lentiviral vector titer. The membrane potentials of 293T cells expressing GFP, HERG, Kv1.4, TREK, or Kir2.1 correlated well with the percentage change
in the lentiviral titer after the addition of the blockers (R2 = 0.95). (D) Reduction in ATP level and its restoration by Ba2+. The ATP levels in 293T cells were
measured 48 h after transfection, without harvesting the lentiviral vectors. The ATP levels were normalized to that of the mock-transfected cells (n = 4,
p < 0.00001; ANOVA followed by Student’s t test).
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tiviral titer. We anticipate that this method will also be ef-
fective for ROMK and epithelial Na+ channels, which
conduct currents in the resting state. The titers and mem-
brane potentials of Kv1.4 and TREK differed in their rank-
ing, which is probably attributable to the incomplete
blockade of the TREK channel by BaCl2.
ATP is reportedly a critical factor in the production of
vaccinia virus [21] and adenovirus [23]. Burgenner et al.
[24] reported a sigmoidal relationship between cellular
ATP levels and reovirus production and suggested that
there is an “ATP threshold” for virus production. Our
data also suggest that reduced ATP plays a causal role in
the phenomenon described here. This is the most likely
explanation because Na+/K+-ATPase consumes 55% of
the energy in renal cells to maintain the appropriate ion
balance [25].Even when the synapsin I promoter was used, the
addition of Ba2+ increased the viral vector titer, whereas the
degree was lower than that of β-actin promoter. This in-
crease is attributed to both the moderate activation of the
promoter and the translation of the transcript from the up-
stream CMV promoter in 293T cells. The activation of the
synapsin I promoter was evident from the slight expression
of GFP in the cells transfected with plasmid Lv-ΔCMV-
synapsinP-Kir2.1 or Lv-ΔCMV-LTR-RRE-cPPT-synapsinP-
Kir2.1, in which the upstream CMV promoter and flanking
elements were deleted. The deletion of the CMV promoter
also resulted in reduced GFP expression, suggesting that
the transcript from the upstream CMV promoter was
translated. For these reasons, the titer of Lv-synapsinP-Kir2.1
was increased by the addition of Ba2+. This would be the
case even if a tissue-specific or inducible promoter were
used for the expression of the gene of interest.
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lentiviral vectors, including the development of pack-
aging cell lines [1,24,26] and the addition of sodium bu-
tyrate [27], fructose [28], a kinase inhibitor [29], and
caffeine [30]. This study provides another option for in-
creasing the lentiviral titer with a simple method. Such
improvements in lentiviral preparation will facilitate
basic neuroscience research and the development of
clinical gene therapies for channelopathies in the future.
Indeed, hippocampal neurons are transduced more ef-
fectively with high-titer viral vectors prepared with K+
channel blockers.Conclusions
Blocking the Kir2.1 current increased the titer of Lv-
Kir2.1 without affecting the infectious ability or stability
of the viral particles. Hippocampal neurons are more ef-
fectively transfected with high-titer viruses than low-
titer viruses. Channel blockers also increased the titers
of lentiviral vectors expressing some other K+ channels,
and the extent of these increases correlated with the cell
membrane potential. Therefore, it may be possible to
predict the effectiveness of channel blockers on lentiviral
titers by measuring the membrane potential of the trans-
fected cells. We anticipate that this method will be ap-
plicable to other ion channels and will facilitate basic
and clinical neuroscience research.Methods
Construction of lentiviral vector plasmids
The construction of the lentiviral self-inactivating ex-
pression plasmid is shown in Figure 1. The expression
plasmid (CS-CDF-CG-PRE) and the helper plasmids
(gag and pol; envelope and rev) were provided by Dr.
Miyoshi (Riken Tsukuba Institute, Ibaraki, Japan). The
downstream CMV promoter of CS-CDF-CG-PRE was
replaced with the promoter of the chick β-actin gene
(donated by Dr. Takeichi, Riken Kobe Institute) or hu-
man synapsin I (donated by Dr. Lois, Caltech). The com-
plementary DNA (cDNA) of GFP was purchased from
Stratagene (La Jolla, CA, USA). cDNAs of mouse Kir2.1,
rat Kv1.4, human TREK-1c, and HERG were donated by
Dr. Jan (UCSF), Dr. Eisenmann (University of Pittsburgh),
Dr. Wischmeyer (University of Würzburg), and Dr.
Robertson (University of Wisconsin), respectively. We
inserted IRES2 between the cDNAs of GFP and the K+
channels for their bicistronic expression. Three-point
mutations in amino acids G144A, Y145A, and G146A
were introduced with PCR to generate the dominant-
negative form of Kir2.1. To construct the ΔCMV plas-
mids, a fragment containing the CMV promoter, LTR,
RRE, and cPPT was deleted with restriction enzyme di-
gestion and self-ligation.Preparation of the lentiviral vectors
The human embryonic kidney (HEK) 293T cells were
maintained in Dulbecco’s modified Eagle’s medium con-
taining 10% fetal bovine serum and 1% penicillin/strepto-
mycin. We transfected the lentiviral self-inactivating
expression plasmid and helper plasmid using the calcium-
phosphate precipitation method [31]. The viral vectors
were pseudotyped with vesicular stomatitis virus G (VSV-
G) protein. Five hours after transfection, the 293T cells
were washed twice with phosphate-buffered saline (PBS)
and incubated in the presence or absence of BaCl2 or
other blockers. We harvested the media 48 h after trans-
fection and removed the debris by centrifugation (1,000 × g
for 3 min at 4°C) and filtration (0.8 μm syringe filter). The
viral particles were concentrated by centrifugation
(58,000 × g for 2 h at 4°C) and suspended in 1/400 volume
of PBS. Blockers of K+ channels, i.e., 0.3 mM BaCl2,
0.5 μM 4-AP, 1 mM BaCl2, and 0.3 μM E-4031, were added
to the media to block the Kir2.1, Kv1.4, TREK-1c, and
HERG channel currents, respectively. Lentiviral vectors
were simultaneously prepared from the control and
current-blocked cells using the same batches of 293T cells
and plasmids. The percentage transfection (~70%) was
similar in all experiments.
The titers of the lentiviral vectors were determined
with the transduction to 293T cells. We prepared se-
quential 10-fold dilutions series (from 5 μl to 50 pl) for
each viral sample in a 96-well plate (triple determina-
tions for each dilution) and added 10,000 293T cells to
each well. We counted the numbers of clusters of GFP-
positive 293T cells 48 h after transduction. We defined
an infectious unit (iu) as the number of transducible
viral vector particles per microliter. The titers of the
synapsin promoter-containing vectors were determined
in pheochromocytoma (PC12) cells (30,000 cells/well),
which were incubated for 4 days after transduction. Be-
cause PC12 cells seem to be vulnerable to K+ channel
expression, BaCl2 (0.3 mM) was added to the medium
during titer determination. The ATP levels were mea-
sured with the CellTiter-Glo® kit (Promega, Fitchburg,
WI, USA).
Hippocampal slice culture
We prepared the hippocampal slices (350 μm thickness)
from postnatal day 7 Sprague Dawley rats and kept them
in culture for 7–13 days in a CO2 incubator at 34°C, as
described previously in other studies [14,32]. Concen-
trated Lv-Kir2.1 solution was injected into the extracel-
lular space of the pyramidal cell layer of the slice culture
with Femtojet® and Femtotips II ® (Eppendorf, Hamburg,
Germany). The slices were incubated for 7 days until fix-
ation. The fixed slices were counterstained with anti-
NeuN antibody (MAB377; Millipore, Billerica, MA, USA)
and a secondary antibody (Alexa-Fluor-568-conjugated
Okada et al. BMC Neuroscience  (2015) 16:30 Page 11 of 12anti-mouse IgG antibody; Molecular Probes, Eugene, OR,
USA) to visualize the neurons.
Electrophysiology
To estimate the IC50, we used a 293T cell line, 56-3, that
stably expresses Kir2.1 with the lentiviral vector Lv-
Kir2.1 [14]. The coverslip on which the 56-3 cells were
grown was transferred to a recording chamber on an
inverted microscope (Olympus IX70, Tokyo, Japan). The
superfusing Tyrode’s solution contained (in mM) 140
NaCl, 5.4 KCl, 0.33 NaH2PO4, 2 CaCl2, 1 MgCl2, 5
HEPES, and 5.5 glucose (pH 7.4). To vary the K+ con-
centration of the perfusate, we added 0%, 5%, 10%, and
15% (v/v) 160 mM KCl and 15%, 10%, 5%, and 0% (v/v)
160 mM NaCl to 85% (v/v) Tyrode’s solution, producing
various K+ concentrations (5, 13, 21, or 29 mM) and
equivalent reductions in the Na+ concentration from
155 mM. The whole-cell currents were recorded from
293T cells using an Axopatch 200B amplifier (Axon In-
struments, Foster City, CA, USA) at 25°C. Patch pipettes
pulled from borosilicate glass (Narishige, Tokyo, Japan)
were filled with an internal solution containing (in mM)
66 K-aspartate, 71.5 KCl, 1 KH2PO4, 5 EGTA, 5 HEPES,
and 3 K2ATP (pH 7.4 adjusted with KOH). The record-
ings were digitized at 10 kHz and low-pass filtered at
2 kHz. The cells were held at –70 mV, and 400-ms step
pulses were applied. The whole-cell conductance was cal-
culated as the slope of the current–voltage relationship
between –140 and –100 mV. The membrane potentials of
the Kir2.1-, Kv1.4-, TREK-, HERG-, and GFP-expressing
cells were measured in the current-clamp mode 24 h after
the transfection of each plasmid. The helper plasmids
were not transfected to ensure the biosafety of the patch-
clamp recorder.
All experiments were approved by the Committee of
Gene Recombination Experiments at Kansai Medical
University. The animal experiments were performed in
accordance with the guidelines of the Physiological Soci-
ety of Japan and were approved by the Committee on
Animal Experiments at our university. All efforts were
made to minimize the number of animals used and their
suffering. Data are shown as the means ± standard errors
of the means (SEM).
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